State Street Corp Cara Therapeutics, Inc. Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

A detailed history of State Street Corp transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 180,400 shares of CARA stock, worth $52,316. This represents 0.0% of its overall portfolio holdings.

Number of Shares
180,400
Previous 180,800 0.22%
Holding current value
$52,316
Previous $47,000 17.02%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$0.26 - $0.38 $104 - $152
-400 Reduced 0.22%
180,400 $55,000
Q2 2024

Aug 14, 2024
SELL
$0.24 - $0.92 $197,316 - $756,381
-822,154 Reduced 81.97%
180,800 $47,000
Q1 2024

May 15, 2024
SELL
$0.52 - $1.05 $9,320 - $18,820
-17,924 Reduced 1.76%
1,002,954 $912,000
Q4 2023

Feb 14, 2024
BUY
$0.6 - $1.65 $57,364 - $157,753
95,608 Added 10.33%
1,020,878 $755,000
Q3 2023

Nov 14, 2023
BUY
$1.67 - $3.33 $9,706 - $19,353
5,812 Added 0.63%
925,270 $1.55 Million
Q2 2023

Aug 14, 2023
SELL
$2.83 - $4.94 $2.78 Million - $4.86 Million
-983,484 Reduced 51.68%
919,458 $2.6 Million
Q1 2023

May 15, 2023
BUY
$4.89 - $12.27 $617,210 - $1.55 Million
126,219 Added 7.1%
1,902,942 $9.34 Million
Q4 2022

Feb 14, 2023
SELL
$8.88 - $12.77 $903,184 - $1.3 Million
-101,710 Reduced 5.41%
1,776,723 $19.1 Million
Q3 2022

Nov 15, 2022
SELL
$8.24 - $12.56 $627,171 - $955,979
-76,113 Reduced 3.89%
1,878,433 $17.6 Million
Q2 2022

Aug 15, 2022
BUY
$7.45 - $13.84 $2.04 Million - $3.79 Million
273,947 Added 16.3%
1,954,546 $17.8 Million
Q1 2022

May 16, 2022
BUY
$9.94 - $12.65 $1.83 Million - $2.33 Million
184,099 Added 12.3%
1,680,599 $20.4 Million
Q4 2021

Feb 14, 2022
SELL
$11.99 - $18.14 $91,915 - $139,061
-7,666 Reduced 0.51%
1,496,500 $18.2 Million
Q3 2021

Nov 15, 2021
SELL
$11.55 - $16.06 $1.31 Million - $1.82 Million
-113,612 Reduced 7.02%
1,504,166 $23.2 Million
Q2 2021

Aug 16, 2021
BUY
$12.38 - $29.19 $8.63 Million - $20.3 Million
696,893 Added 75.68%
1,617,778 $23.1 Million
Q1 2021

May 17, 2021
SELL
$15.07 - $21.71 $627,876 - $904,525
-41,664 Reduced 4.33%
920,885 $20 Million
Q4 2020

Feb 16, 2021
BUY
$12.72 - $16.16 $165,563 - $210,338
13,016 Added 1.37%
962,549 $14.6 Million
Q3 2020

Nov 10, 2020
SELL
$12.34 - $17.92 $652,539 - $947,609
-52,880 Reduced 5.28%
949,533 $12.1 Million
Q2 2020

Aug 14, 2020
SELL
$12.39 - $17.33 $231,160 - $323,325
-18,657 Reduced 1.83%
1,002,413 $17.1 Million
Q1 2020

May 11, 2020
BUY
$9.12 - $17.78 $9.31 Million - $18.2 Million
1,021,070 New
1,021,070 $13.5 Million

Others Institutions Holding CARA

# of Institutions
74
Shares Held
12.8M
Call Options Held
0
Put Options Held
0
View Full List

About Cara Therapeutics, Inc.

CARA Quotes by TradingView
  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $15.6M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email